Overview
- 59 inspections across 51 sites are on record.
- 121 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-01-10.
At a glance
Inspections
59
Sites
51
Observations
121
Career since
Jan 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Amneal Pharmaceuticals of New York, LLC | 10 Jan 2013 | On file | |
| Central Boeki U.S.A. LTD. | 28 Dec 2012 | View 483 → | |
| Alphas Co. of NY Inc. | 4 Dec 2012 | ||
| Morris Okun, Inc. | 28 Nov 2012 | ||
| Neviot Corp. | 15 Nov 2012 |
Sites inspected
Amneal Pharmaceuticals of New York, LLCBrookhaven, United States1 insp.
Central Boeki U.S.A. LTD.Long Island City, United States1 insp.
Alphas Co. of NY Inc.Bronx, United States1 insp.
Morris Okun, Inc.Bronx, United States1 insp.
Neviot Corp.Arverne, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sarah A Wangseng11 shared
Amber D Brodas4 shared
Anthony R Rauert3 shared
Samantha N Mccormick2 shared
Valerie A Potopsingh2 shared
Peter M Trunk2 shared
Eric J Reisenauer2 shared
Jane Chen2 shared
Robert C Steyert1 shared
Kimberley A Ricketts1 shared
Full investigator report
Get the verbatim findings behind Tara K Normandin's 121 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site